Found 1 articles for: "Refractory Dermatomyositis"

A Retrospective Review of Tofacitinib in the Treatment of Refractory Dermatomyositis

October 2022 | Volume 21 | Issue 10 | Editorials | 1133 | Copyright © October 2022

Dermatomyositis (DM) is an autoimmune myopathy with characteristic dermatologic features.¹ Tofacitinib is an immunomodulator with proven efficacy against numerous immune-mediated disorders,...
Read More